Upregulation of several genes, including IGFBP4, RGS2, and WNT5A, that mediate several functions, including growth, differentiation, proliferation, apoptosis, and angiogenesis [55,56,57], were observed in cancer cells after their treatment with DBMSCs. This evidence concerns the gene RGS2 and cancer.